Vivani Medical Stock EBITDA
| VANI Stock | USD 1.33 0.04 3.10% |
Vivani Medical fundamentals help investors to digest information that contributes to Vivani Medical's financial success or failures. It also enables traders to predict the movement of Vivani Stock. The fundamental analysis module provides a way to measure Vivani Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vivani Medical stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -26.6 M | -27.9 M |
Vivani | EBITDA |
Vivani Medical Company EBITDA Analysis
Vivani Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Vivani Medical EBITDA | (26.61 M) |
Most of Vivani Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vivani Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Vivani EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Vivani Medical is extremely important. It helps to project a fair market value of Vivani Stock properly, considering its historical fundamentals such as EBITDA. Since Vivani Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vivani Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vivani Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Vivani Ebitda
Ebitda |
|
According to the company disclosure, Vivani Medical reported earnings before interest,tax, depreciation and amortization of (26.61 Million). This is 103.03% lower than that of the Biotechnology sector and 104.14% lower than that of the Health Care industry. The ebitda for all United States stocks is 100.68% higher than that of the company.
Vivani EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vivani Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vivani Medical could also be used in its relative valuation, which is a method of valuing Vivani Medical by comparing valuation metrics of similar companies.Vivani Medical is currently under evaluation in ebitda category among its peers.
Vivani Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Vivani Medical from analyzing Vivani Medical's financial statements. These drivers represent accounts that assess Vivani Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Vivani Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 87.3M | 38.5M | 53.9M | 32.5M | 37.4M | 35.5M | |
| Enterprise Value | 78.6M | 38.9M | 53.6M | (11.6M) | (13.4M) | (12.7M) |
Vivani Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Vivani Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Vivani Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vivani Medical's value.| Shares | Charles Schwab Investment Management Inc | 2024-09-30 | 30 K | Two Sigma Securities, Llc | 2024-06-30 | 25.7 K | Group One Trading, Lp | 2024-06-30 | 14.4 K | Tower Research Capital Llc | 2024-06-30 | 13.4 K | Susquehanna International Group, Llp | 2024-06-30 | 10.3 K | Goss Wealth Management Llc | 2024-06-30 | 1.4 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.1 K | Royal Bank Of Canada | 2024-06-30 | 490 | Qube Research & Technologies | 2024-06-30 | 402 | Sabby Management Llc | 2024-06-30 | 2.1 M | Tanager Wealth Management Llp | 2024-09-30 | 1.3 M |
Vivani Fundamentals
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | 76.45 M | ||||
| Shares Outstanding | 59.23 M | ||||
| Shares Owned By Insiders | 52.50 % | ||||
| Shares Owned By Institutions | 10.46 % | ||||
| Number Of Shares Shorted | 754.37 K | ||||
| Price To Book | 4.17 X | ||||
| Gross Profit | 130 K | ||||
| EBITDA | (26.61 M) | ||||
| Net Income | (25.65 M) | ||||
| Cash And Equivalents | 3.45 M | ||||
| Cash Per Share | 0.28 X | ||||
| Total Debt | 20.7 M | ||||
| Current Ratio | 1.35 X | ||||
| Book Value Per Share | 0.41 X | ||||
| Cash Flow From Operations | (23.7 M) | ||||
| Short Ratio | 12.59 X | ||||
| Earnings Per Share | (0.43) X | ||||
| Target Price | 5.5 | ||||
| Number Of Employees | 36 | ||||
| Beta | 3.52 | ||||
| Market Capitalization | 76.41 M | ||||
| Total Asset | 45.8 M | ||||
| Retained Earnings | (98.44 M) | ||||
| Working Capital | 17.34 M | ||||
| Net Asset | 45.8 M |
About Vivani Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vivani Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vivani Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vivani Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Vivani Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vivani Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vivani Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vivani Medical Stock:Check out Vivani Medical Piotroski F Score and Vivani Medical Altman Z Score analysis. For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivani Medical. If investors know Vivani will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivani Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.43) | Return On Assets (0.29) | Return On Equity (0.86) |
The market value of Vivani Medical is measured differently than its book value, which is the value of Vivani that is recorded on the company's balance sheet. Investors also form their own opinion of Vivani Medical's value that differs from its market value or its book value, called intrinsic value, which is Vivani Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivani Medical's market value can be influenced by many factors that don't directly affect Vivani Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivani Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivani Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivani Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.